Anti-p200 pemphigoid responding to dapsone
Anti-p200 pemphigoid is a rare autoimmune subepidermal blistering disease. Clinical presentation is similar to standard bullous pemphigoid (BP) but mucous membranes and cephalic lesions are more frequent. Histology and direct immunofluorescence (IF) are identical to BP but indirect IF discloses line...
Main Authors: | Laura Van Lerberghe, Audrey Lasek, Pierre Gosset, Fabienne Jouen, Philippe Modiano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-03-01
|
Series: | Dermatologica Sinica |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1027811713000256 |
Similar Items
-
Dapsone – mechanism of action, safety of use and the role in the treatment of bullous pemphigoid according to current recommendations
by: Magdalena Żychowska, et al.
Published: (2016-05-01) -
Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic Glucocorticoid
by: Kenneth Thomsen, et al.
Published: (2019-06-01) -
Bullous pemphigoid: Management during COVID-19 pandemic
by: Ajit B Janagond, et al.
Published: (2021-01-01) -
Clinicoepidemiological Features of 82 Cases of Bullous Pemphigoid in Tehran, Iran
by: Kamran Balighi, et al.
Published: (2018-11-01) -
A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid
by: Iria Neri, et al.
Published: (2021-02-01)